{
  "name" : "dacemirror.sci-hub.se_journal-article_05af605e2970a4b734f2440eca225a58_zhao2019.pdf",
  "metadata" : {
    "source" : "META",
    "title" : "Microfluidic Generation of Nanomaterials for Biomedical Applications",
    "authors" : [ "Xin Zhao", "Feika Bian", "Lingyu Sun", "Lijun Cai", "Ling Li", "Yuanjin Zhao" ],
    "emails" : [ "li-ling76@hotmail.com;", "yjzhao@seu.edu.cn" ],
    "sections" : [ {
      "heading" : null,
      "text" : "1901943 (1 of 19) © 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim\nREVIEW www.small-journal.com\nMicrofluidic Generation of Nanomaterials for Biomedical Applications\nXin Zhao, Feika Bian, Lingyu Sun, Lijun Cai, Ling Li,* and Yuanjin Zhao*\nDr. X. Zhao, Prof. L. Li, Prof. Y. J. Zhao Department of Endocrinology Zhongda Hospital School of Medicine Southeast University Nanjing 210009, P. R. China E-mail: li-ling76@hotmail.com; yjzhao@seu.edu.cn Dr. X. Zhao Research Institute of General Surgery Jinling Hospital Medical School of Nanjing University Nanjing 210002, P. R. China Dr. F. K. Bian, Dr. L. Y. Sun. Dr. L. J. Cai, Prof. Y. J. Zhao State Key Laboratory of Bioelectronics School of Biological Science and Medical Engineering Southeast University Nanjing 210096, P. R. China\nThe ORCID identification number(s) for the author(s) of this article can be found under https://doi.org/10.1002/smll.201901943.\nDOI: 10.1002/smll.201901943\nInorganic NPs, mainly including metal, metal oxide, and quantum dots (QDs), have unique optical, electrical, and magnetic properties.[6–9] Organic NPs generated from biocompatible polymers such as carbohydrates, proteins, lipids, or various synthetics, can deliver drugs, nucleic acids, or imaging components in vivo.[10–13] NFs are spinned from synthetic or natural polymers, which can be woven into fibrous scaffolds or combined with stem cell biotechnology, taking important parts in regenerative medicine.[14–18] Therefore, the development of new NMs for the diagnosis and/or treatment of different diseases has received increasing attentions in recent years and now become a hot spot in medical research.[19–22] However, translation of NMs to the clinic has been retarded, and the majority of them cannot even reach the stage of in vivo\nevaluation.[23–25] One of the main reasons is that reproducible synthesis of NMs having identical properties and sufficient quantities remains difficult.[26–28] Although many preparation methods have been applied to generate NMs, majorities suffer from poor control over reaction conditions, resulting in heterogeneity of obtained NMs.[29–32] Thus, there is an urgent need for developing an easily-manipulated technique to synthesize high-quality NMs.\nSince emerged in the early 1980s, microfluidics has become a highly interdisciplinary science and technology that handle single-phase or multiple-phase fluids in channels with inner diameters ranging from tens to hundreds of micrometers.[33–38] On the microscale dimensions, the fluid behavior is primarily controlled by viscosity rather than inertia, and the high ratio of surface area to volume provides rapid heat and mass transfer.[39–43] Such features make microfluidic technologies effective tools for a broad range of applications including biology, medicine, chemistry and engineering sciences.[44–48] For materials fabrication, microfluidics executes precise control over reaction procedures, and generates NMs with a defined size and morphology.[49–57] Owing to the homogeneous reaction environment, the production efficiency and monodispersity of generated materials from microfluidics are much higher than those from conventional methods.[58–60] In addition, through designing customized microchannels, introducing specific physicochemical processes and incorporating functional agents, the structures and functions of the NMs are extremely flexible.[61–64] Therefore, microfluidics offers an excellent platform for synthesizing libraries of NMs with high quality,\nAs nanomaterials (NMs) possess attractive physicochemical properties that are strongly related to their specific sizes and morphologies, they are becoming one of the most desirable components in the fields of drug delivery, biosensing, bioimaging, and tissue engineering. By choosing an appropriate methodology that allows for accurate control over the reaction conditions, not only can NMs with high quality and rapid production rate be generated, but also designing composite and efficient products for therapy and diagnosis in nanomedicine can be realized. Recent evidence implies that microfluidic technology offers a promising platform for the synthesis of NMs by easy manipulation of fluids in microscale channels. In this Review, a comprehensive set of developments in the field of microfluidics for generating two main classes of NMs, including nanoparticles and nanofibers, and their various potentials in biomedical applications are summarized. Furthermore, the major challenges in this area and opinions on its future developments are proposed.\nMicrofluidic Nanomaterials"
    }, {
      "heading" : "1. Introduction",
      "text" : "Nanomaterials (NMs) are showing great promise in biomedical fields since they have size-, shape-, and composition-dependent physical, chemical, optical, and electronic properties.[1–5] Broadly, NMs can be divided into nanoparticles (NPs) and nanofibers (NFs), according to the different shapes. To facilitate describing their functions in diagnostics and therapeutics, NPs are further categorized as inorganic or organic particles.\nSmall 2019, 1901943\n1901943 (2 of 19)\nwww.advancedsciencenews.com\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim\nwww.small-journal.com\nsignificantly accelerating the development and clinical translation of nanomedicines.\nFabrication of microfluidic chips with well-defined geometry and material compatibility is the first and fundamental step for generating NMs by microfluidics.[65,66] The rapid development of micro- and nanofabrication techniques have largely contributed to the revolution of microfluidic device, and previous reviews have summarized primary methods for design of microfluidic device in detail.[67,68] Two dominant types of microfluidic chips were used in generating various types of NMs.[69–71] One is glass capillary microfluidic chip that has advantages of high chemical resistance and ideal coaxial construction. These properties make them suitable for preparation of continuous and segmented flows with various compositions and structures.[72,73] The other is lithographically fabricated poly(dimethylsiloxane) (PDMS) chip that can simply integrate a number of identical channels, making them attractive for largescale production of NMs.[74,75]\nUp to now, a number of reviews about microfluidic fabrication of materials have been reported from different aspects, which mainly refer to certain microfluidic technologies (e.g., droplet microfluidics) or specific forms of materials (e.g., microparticles).[76–80] However, a comprehensive review that puts the attention on microfluidic fabrication of NMs and their biomedical applications is unavailable. In this review, we introduced the basic fabrication mechanism of NPs and NFs using microfluidics, which could be simply classified into continuous flow and segmented flow. Recent progress on microfluidic synthesis of advanced NMs was highlighted. Then, we described the biomedical applications of these NMs, focusing on their advanced functions in drug delivery, biosensing, bioimaging, and tissue engineering. Finally, a brief outlook on the future development of microfluidic techniques for NMs fabrication was presented."
    }, {
      "heading" : "2. Microfluidic Generation of NPs",
      "text" : "In recent decades, NPs have drawn significant attention in biomedicine because of their extensive applications in drug delivery systems, contrast agents, diagnostic tools and antennas for photothermal therapy.[81–85] The formation of NPs can be roughly divided into three stages: nucleation, growth and agglomeration.[86–88] In a conventional batch synthesis, the three stages are poorly controlled and inevitably occurring at the same time, thus it is technically challenging to fabricate NPs with a uniform size and desired structure.[89,90] In addition, stepwise preparation of complex NPs in batch reactors is laborious and has poor reproducibility, which imposes evident restrictions on their functionalities and applications.[91,92] Therefore, the intrinsic limitations of conventional batch methods have long prevented the NPs from translation to the clinic.\nIn the last decades, a large amount of research efforts have been devoted to microfluidic synthesis of NPs. Microfluidics is demonstrated to possess of several advantages, including: i) high surface area to volume ratio, rapid mass, and heat transfer in the microchannel; ii) homogeneous and well-defined reaction conditions; iii) the occurrence of NPs nucleation and\ngrowth away from the position where solution mixing takes place; iv) minimizing use of expensive or toxic chemicals.[93–96] Therefore, the developments of microfluidic systems can facilitate synthesis of NPs with high quality. Here, we offered an overview of the microfluidic NPs using either inorganic or organic materials, and their applications in biomedical areas, after a brief description of fabrication mechanism underlying microfluidic systems."
    }, {
      "heading" : "2.1. Basic Fabrication Mechanism",
      "text" : "Based on the flow behavior, the general principles used in microfluidics for fabricating NPs are divided into continuous flow and segmented flow with liquid–liquid or gas–liquid interfaces."
    }, {
      "heading" : "2.1.1. Continuous Flow",
      "text" : "A single-phase continuous flow system is the most widely used strategy in microfluidic synthesis of NPs, in which continuous flow of precursor fluids runs through the microchannel where nucleation and growth take place (Figure 1a).[93,97,98] This type of microfluidic system is very simple and has been demonstrated as a powerful platform to control over the flow rates, reagent concentrations, residence time and reaction temperature. In addition, NPs can be easily modified by adding new reagents at any demanded time point during the reaction procedures.[99–101] The single-phase continuous flow strategy is\nXin Zhao received his Ph.D. degree in 2019 from Medical School of Nanjing University. His research interest is in the fabrication of functional materials based on microfluidics for controllable drug delivery and tissue regeneration.\nYuanjin Zhao received his Ph.D. degree in 2011 from Southeast University. In 2009–2010, he worked as a research scholar at Prof. David A. Weitz’s group at Harvard University. Since 2015, he was promoted to be a full professor at Southeast University. His current scientific interests include microfluidics, ferrofluids, biomaterials, and organs-on-chips.\nSmall 2019, 1901943\n1901943 (3 of 19)\nwww.advancedsciencenews.com\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim\nwww.small-journal.com\nalso highly scalable, and the throughput can be dramatically increased by integrating multiple identical microchannels parallelly on the same lamina.[102,103] Hydrodynamic focusing (HF) techniques are also categorized as a specific type of continuous flow microfluidics. In a basic HF design, a sheath solution with a higher flow rate is employed to compress a central solution with a lower flow rate from all directions (Figure 1a).[93,104,105] Owing to the decreased diffusion distance, this compression evidently reduces the mixing time, thus can improve the quality of synthesized NPs. The diameter of the resultant NPs could be regulated by altering the relative flow rate between the central and sheath solution. In addition, when the reaction is restricted within a focused central flow, the channel wall is isolated from the precursors to avoid clogging, thus the consistent formation of NPs can maintain for a long period.[106,107]"
    }, {
      "heading" : "2.1.2. Segmented Flow",
      "text" : "Alongside the continuous flow, segmented flow microfluidic system was also presented to synthesize NPs. Various geometries of microfluidic devices (e.g., T-junction, co-flow, and flow-focusing, as shown in Figure 1b) were designed to generate segmented flows, which include a liquid–liquid interfacial layer for droplets and a gas–liquid interfacial layer for bubbles (Figure 1c).[53,78,108–110] In a liquid–liquid segmented flow, the droplets breakup is resulted from the instability of dispersed phase, and presented as water-in-oil or oil-in-water emulsions. Many parameters can regulate the droplets formation, such as microchip construction, solution viscosity and flow rate, which in turn decide the size and structure of the resultant NPs. The uniform droplets can serve as excellent reactors to carry out\nSmall 2019, 1901943\n1901943 (4 of 19)\nwww.advancedsciencenews.com\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim\nwww.small-journal.com\nchemical reactions on a microscale dimension. Because of the consistent residence time, adequate mixing efficacy, quick heat and mass transfer afforded by each microdroplet, the NPs with high quality can be synthesized continuously.[95,111–113] In a gas–liquid segmented flow, it is always presented as a series of uniform bubbles dispersed in a continuous liquid phase. The gas bubbles can be pumped into the microfluidic chip in a controlled manner and are demonstrated to be highly flexible and simply separable. Therefore, these microfluidic bubbles can be used to act as excellent micromixers for synthesizing NPs.[8,114,115]"
    }, {
      "heading" : "2.2. Microfluidic Generation of Inorganic NPs",
      "text" : "Inorganic NPs have become promising candidates for biomedical applications in optical and electrical sensing, diagnosis, photothermal therapy, optogenetics and a few others.[116–118] The monodispersity of inorganic NPs is highly dependent on the reaction parameters such as mixing time and temperature during the synthetic procedure.[119,120] Owing to the ability of manipulating fluids at the microscale dimension, microfluidics can promote rapid mixing of the injected precursor solutions,\nprecisely control temperature alteration at different time point, and thus generate inorganic NPs with a defined size and structure. For example, Chan et al. introduced a curved, 65 cm long microfluidic channel with a heated section to synthesize CdSe NPs in a continuous flow. They demonstrated that the generated NPs would become larger when the reaction environment was heated up, the precursor concentration was increased, or the flow rate was slowed down.[121] In another study, iron oxide NPs have been successfully synthesized using microfluidic platforms. The single-phase microchip based on patterned plates was divided into a mixing zone and a reaction zone, and allowed for efficient decomposition of Fe3+ precursor within a short residence time (Figure 2a). The resultant iron oxide NPs possessed high crystallinity, purity, and magnetization, which indicated their favorable application prospect in the future.[99]\nTaking advantages of HF flow afforded by a coaxial microchip, Roig et al. generated ZnO NPs with homogeneous nanostructures and advanced optical properties (Figure 2b).[122] The HF design could prevent microchannel clogging, which was often encountered in the single-phase microfluidic system. Because the procedures of nucleation/growth and functionalization happened in separated positions in the microchip, the decorated ratio of functional groups on the surface of ZnO NPs\nSmall 2019, 1901943\n1901943 (5 of 19)\nwww.advancedsciencenews.com\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim\nwww.small-journal.com\ncould be well controlled. Another example of HF microfluidics applied to synthesize inorganic NPs was reported by Gómez-de Pedro et al.[123] They successfully fabricated monodispersed and stable CdS NPs with a mean diameter of about 4.5 nm. Compared to batch processes, the HF process provided a highly automated, exhaustively controlled reaction kinetics by regulating the concentrations of reagents addition, the flow rates of hydrodynamic fluids and the conformation of microchips. Owing to these advantages, NPs with excellent optical properties could be reproducibly synthesized and showed great potentials in future analytical applications.\nA droplet-based microfluidic chip was designed for the synthesis of AgNPs, as shown in Figure 2c.[108] The aqueous solutions of a metal precursor and a reducing agent were injected into the customized microreactor to form a laminar flow, and then sheared into droplets by a continuous oil phase. As analyzed by X-ray diffraction, UV–vis spectroscopy, and transmission electron microscope (TEM), the resultant AgNPs were produced with high-quality and monodispersity, owing to the rapid and efficient mixing in individual droplets. In another study, Tang et al. also reported a droplet-based microfluidic chip for efficiently producing eutectic gallium indium (EGaIn) NPs.[124] The EGaIn precursor and suspension medium was respectively pumped into the T-shaped microchannel which was widely used for generating microdroplets. Under the action of acoustic waves, the droplets were disrupted into nanoscale EGaIn particles in an aqueous environment. Therefore, the simplicity and versatility of the droplet-based microfluidics make it an ideal platform for the synthesis of inorganic NPs.\nThe detailed information of the aforementioned inorganic NPs generated from microfluidic systems was summarized in Table 1. As high reaction temperature was often a requirement for synthesizing inorganic NPs, the materials used to construct microfluidic chip should be conducive to heat transfer and resistant to thermal erosion. Residence time was another significant consideration during the synthetic process. If the inorganic NPs stayed in the microchip for a long time, the generation course was unstable, the morphological transformation process would lead to the heterogeneity of resultant NPs, and the microfluidic channel had a high tendency to block. Solving these two problems, the microfluidics was demonstrated to be a strong platform for synthesizing various kinds of inorganic NPs with a high uniformity."
    }, {
      "heading" : "2.3. Microfluidic Generation of Organic NPs",
      "text" : "Polysaccharides are promising polymers in biomaterials which have many advantages over synthetic polymers, such as their natural abundance, generally low cost, easy manipulation and excellent biocompatibility.[125] The application of microfluidic techniques to these polymers for manufacturing NPs has become an interesting topic in scientific research.[126] For example, Pessoa et al. designed four different HF microfluidic chip with various geometries for the synthesis of chitosan NPs (Figure 3a): D-simple with a short straight channel, D-long with a long curved channel, D-bends with a long bended channel, and D-barriers with a long channel separated by interval barriers.[127] The results showed that the establishment of an enough diffusion length in the microchip was essential for the continuous and homogeneous generation of NPs. In another study, Kim et al. proposed microfluidic generation of alginate NPs through polyelectrolyte complexation in the microchannel.[128] As shown in Figure 3b, the Ca-alginate pregel solution and poly-l-lysine solution were pumped into the microchip through two different inlets, and then underwent efficient mixing to translate into alginate NPs. By simply changing the flow rates of the reaction solutions, the diameter of resultant NPs could be well controlled. In addition, hyaluronic acid NPs have also been successfully synthesized by microfluidic chip with an enhanced stability and uniformity.[129]\nLiposomes or lipid NPs (LNPs) are self-assembled phospholipid vesicles and present an amphipathic property which allows for encapsulation of both hydrophobic and hydrophilic bioactive molecules.[130] In order to overcome the bottlenecks of traditional fabrication methods, microfluidics has been proposed to translate these phospholipid materials into advanced drug delivery system. For example, taking advantages of herringbone microfluidic chip proposed by Stroock et al. in 2002,[131] Belliveau et al. successfully generated a kind of very small and well monodisperse LNPs within a short mixing time (about 3 ms). As shown in Figure 3c, the specially designed oblique grooves on the bottom of the channel could produce chaotic flows to fully mix the reaction solutions and enhance the substance diffusion in the system.[132] Kim et al. applied the similar microfluidic chip in manufacturing of colloidally stable cubosomes (a lipid-based cubic NPs). The mixing kinetics in small\nSmall 2019, 1901943\n1901943 (6 of 19)\nwww.advancedsciencenews.com\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim\nwww.small-journal.com\nvolumes was significantly improved, the process of solvent extraction was precisely controlled, and the generated cubosomes were uniform with an average diameter of about 200 nm.[133] In another experiment, Jahn et al. utilized HF microfluidics to fabricate LNPs with a desired relative standard deviation (Figure 3d).[134] The on-chip synthesis could also offer a platform to investigate the self-assembly process of lipid molecules under various reaction parameters. Furthermore, taking advantages of the microfluidic mixing techniques, not only the small molecule drugs and small interfering RNA (siRNA), but also the bioactive macromolecules could be encapsulated into liposomes with a high efficiency.\nPoly(l-lactide-co-glycolide) (PLGA) is a biocompatible and biodegradable copolymer that is already approved by Food and Drug Administration and European Medicines Agency for clinical applications. In order to generate PLGA NPs in a rapid, reliable and reproducible manner, various types of microfluidic systems have been specially designed. For example, Libi et al. reported a simple continuous-flow microfluidic chip for synthesizing PLGA NPs.[135] Through solvent extraction to the aqueous phase, the polymeric precursors in the microchannel could be rapidly precipitated to form NPs. Compared to the batch methods, the microfluidic method allowed for the synthesis of PLGA NPs with a narrow size distribution and a mean diameter of about 200 nm. The mixing efficiency is an important factor to decide the monodispersity of the generated NPs in microfluidics. In order to further improve the mixing efficiency, microfluidic system with 3D coaxial flow was designed to synthesize PLGA NPs.[74] The co-flow geometry contributed to the rapid mass transfer and reduced mixing distances in the microchannel, thus providing a homogeneous environment for nucleation and growth of NPs. A droplet-based microfluidic system has also been well constructed to synthesize PLGA NPs (Figure 3e).[136] The two T-junctions of the microchip were used to generate PLGA precursor droplets and water droplets in silicone oil phase, respectively. Upon fusion of the two droplets,\nSmall 2019, 1901943\n1901943 (7 of 19)\nwww.advancedsciencenews.com\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim\nwww.small-journal.com\nPLGA NPs were precipitated out immediately due to the small volume of the droplets. Furthermore, the uniformity in droplet size permitted the homogeneous reaction conditions in each droplet, and allowed for synthesizing PLGA NPs with excellent monodispersity.\nThe detailed information of the aforementioned organic NPs generated from microfluidic systems was summarized in Table 2. As we all know, a rapid and efficient mixing between different reaction flows is very important for synthesizing organic NPs with a narrow size distribution. To better satisfy the requirements, microfluidic systems have been further designed in reported studies. On one hand, HF was commonly introduced to narrow the central flow of NP precursor, which resulted in an enhanced diffusive mixing occurring rapidly across its width. On the other hand, the application of microchannels patterned with special grooves was also an effective way to control the mixing conditions in microfluidic system. These patterned structures could induce chaotic advection by stirring the reaction fluids perpendicular to the direction of stream, and generate efficient mixing flows in the microchannel to accelerate the progress of nanoprecipitation. We found that these microfluidic systems could ensure the homogeneity of resultant organic NPs, with average particle sizes ranging from a few tens to a few hundreds of nanometers."
    }, {
      "heading" : "2.4. Microfluidic Generation of Complex NPs",
      "text" : "Hybrid NPs are expected to show properties that are not available by the individual component, and have attracted widespread interest in the design of materials for biomedicine.[137] Cheheltani et al. used a single-phase microfluidic system to encapsulate AuNPs into poly di(carboxylatophenoxy)phosphazene (PCPP) nanospheres.[138] The hybrid NPs (Au-PCPP) showed great application values in photoacoustic imaging, because of the combination of high X-ray attenuation of AuNPs with biocompatible and biodegradable of PCPP. By regulating the AuNPs concentration and the size of Au-PCPP, the absorbance could be shifted into the near infrared (NIR), which\nwas an important feature making Au-PCPP an excellent kind of imaging contrast agents. In another study, Huang et al. successfully used an HF microfluidic system to generate polymer-lipid hybrid NPs (PLNPs) for siRNA delivery. Compared to those fabricated by batch methods, the resulting hybrid NPs had a narrower size distribution and lower surface charge. Furthermore, the PLNPs combined the advantages of both liposomes and NPs, such as high stability, biocompatibility and controlled release properties, thus having a great promise in drug delivery applications.[139]\nMetal-organic frameworks (MOFs) are one of the most investigated nanohybrids, derived from organic ligands bound periodically by metal clusters. MOFs have tunable porous crystalline structures and diverse chemical functionalities, which can be regulated by varying the ratio of the two components. Therefore, they have attracted extensive attentions owing to their promising possibilities for biomedical applications.[140] The feasibility of applying droplet-based micro fluidic approach for crystallization of MOFs was demonstrated by Faustini et al.[141] As shown in Figure 4a, the microdroplets were generated by a T-junction microfluidic chip, and then experienced solvothermal processes to synthesize MOFs. Owing to the large specific surface area, high mixing efficiency and homogeneous reaction kinetic in each droplet, the MOFs were generated with desired structures and dramatically reduced time. Similar microfluidic system was also used by Paseta et al. to synthesize MOFs with three different organic ligands. The results showed that microfluidics executed excellent control over the particle morphology and function with a good universality.[142]\nCore–shell NPs usually have a hydrogel, liquid or hollow core protected by a solid shell.[143] The application of microfluidic method for preparation of this type of nanostructures is promising, which avoids complicated coating and purification processes required in conventional methods. Zhang et al. designed a microfluidic chip with three sections to synthesize water core-PLGA shell-lipid layer NPs for encapsulating hydrophilic agents with high efficiency (Figure 4b). The first section was used to introduce aqueous flow for loading hydrophilic\nSmall 2019, 1901943\nTable 2. Detailed information about microfluidic generation of organic NPs.\nRef. NPs Microfluidic device\nFlow behavior\nFlow rates [µL min−1]\nRe Average size\nSize distribution\n[127] Chitosan PDMS (HF) Continuous Vi: 25\nVo: 32.5\n17.5 129 nm PDI: 0.12\n[128] Alginate Polypropylene Continuous 1000 – 150 nm –\n[129] Hyaluronic Glass plate (HF) Continuous Vi: 40\nVo: 70\n6.88 217 nm PDI: 0.04\n[132] Lipid PDMS (herringbone) Continuous 2000 2–500 55 nm PDI: 0.03\n[133] Lipid PDMS (herringbone) Continuous 50 2–500 201 nm PDI: 0.04\n[134] Lipid Silicon wafer (HF) Continuous Vo/ Vi: 12 – 40 nm CV: 0.10\n[135] PLGA Polyvinyldene fluoride Continuous 1000 – 197 nm PDI: 0.20\n[74] PLGA Glass capillaries (HF) Continuous Vi/Vo: 1000 40 200 nm PDI: 0.10\n[136] PLGA PDMS (T-junction) Segmented Vwater = VPLGA – 70 nm PDI: 0.14\nRe: Reynolds number; Vi: the flow rate of inner phase; Vo: the flow rate of outer phase; PDI: polydispersity index; CV: coefficient of variation.\nwww.advancedsciencenews.com\nwww.small-journal.com\nagents; the second section was used to introduce PLGA flow for generating a rigid shell; the third section was used to introduce lipid flow for depositing the outermost layer. This specially designed microfluidic chip could synthesize the core–shell NPs in a continuous step and avoid using toxic emulsifiers and stabilizers which were very common in bulk methods.[144] Alternatively, Bochicchio et al. applied a continuous-phase microfluidic system to produce core–shell NPs composed of a liposomal core surrounded by a chitosan coating.[145] As shown in Figure 4c, the prepared suspension of nanoliposomes and chitosan solution were pumped into the microchip respectively to decorate nanoliposomes with a layer of chitosan. The TEM results indicated that the covered chitosan shell was uniform, continuous and smooth, which was difficult to realize in traditional methods. This morphological feature could enhance the stability of the resultant NPs in biological fluids and improve their performance in drug delivery. The detailed information of the aforementioned complex NPs generated from microfluidic systems was summarized in Table 3. There were two basic protocols adopted by investigators to synthesize this type of NPs. The easier method was to dissolve multiple ingredients into the precursor solution in advance, and then pump them into the microchannel to generate NPs with complex components. Another method was to design multistage microfluidic device, and then add specific ingredient in each stage sequentially to generate NPs with complex structures. No matter which protocol was used, the polydispersity of complex NPs was generally higher than pure inorganic or organic ones, which might be caused by the interactions between different components or the multistep synthetic procedures.\n1901943 (9 of 19)\nwww.advancedsciencenews.com\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim\nwww.small-journal.com"
    }, {
      "heading" : "2.5. Biomedical Applications of NPs from Microfluidics",
      "text" : ""
    }, {
      "heading" : "2.5.1. Drug Delivery",
      "text" : "NPs are capable of encapsulating various types of drugs, improving their solubility and stability, releasing them in a controllable manner and reducing their toxic effects. In addition, the nanoscale size enables their passive diffusion into solid tumors with enhanced permeability and retention effect, remarkably improving the therapeutic selectivity of the encapsulated agents.[23,146–148] The controllability of NPs-based drug delivery system is largely dependent on the size, morphology, structure and composition, however, these physicochemical properties could not be well-defined by conventional fabrication\nSmall 2019, 1901943\n1901943 (10 of 19)\nwww.advancedsciencenews.com\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim\nwww.small-journal.com\nmethods.[149] Recent applications of microfluidic technologies to drug delivery system development have contributed to the emergence of plentiful excellent drug nanocarriers. For example, Chen et al. designed a PDMS-based microfluidic chip to produce curcumin-loaded polymer NPs (CUR-PNPs) by generating gas-segmented liquid plugs (Figure 5a).[150] Compared to conventional nanoprecipitation method, the CUR-PNPs prepared by microfluidics showed narrower size distributions and increased encapsulation efficiency. Additionally, by regulating the flow rates in the microchannel, the diameter of the resultant NPs could be optimized, thus providing an efficient mean to control the pharmacokinetics of CUR-PNPs. The same advantages of microfluidics were also found by Martins et al. during the fabrication of central nervous system (CNS)targeted, efavirenz (EFV)-loaded PLGA NPs for human immunodeficiency virus (HIV) therapy (Figure 5b).[151] Furthermore, the microfluidic NPs were also demonstrated to meet the safety requirements for intravenous administration, and avoid cytotoxicity in relation to the application of free-form EFV.\nBesides polymer NPs, porous silica NPs (PSNPs) have also been synthesized by microfluidics to act as drug carriers. Liu et al. designed a flow-focusing microfluidic chip to generate a novel kind of PSNPs-based nanocarriers. By sealing the pores of PSNPs using acid-degradable acetalated dextran, three model drugs with different physicochemical properties were all successfully encapsulated into the nanocomposites with a high loading efficiency. Because of their responsiveness to pH value alteration, the degradation rate of the nanocomposites and the release rate of the encapsulated drugs could be precisely controlled.[152] Using a similarly designed microfluidic chip, Herranz-Blanco et al. developed an intelligent multistage drug delivery system based on PSNPs. Owing to the high mixing efficiency provided by the microchip, the nanocarriers possessed favorable monodispersion, improved surface smoothness, and thus exhibited enhanced stability in plasma.[153] In another study, Fontana et al. used microfluidic technology to decorate cancer cell membrane on the surface of PSNPs for cancer immunotherapy. The resultant nanovaccines could up-regulate the expression of co-stimulatory signals in different cell lines and enhance Th1 cell-mediated immunoresponse, thus showed great potentials in the application of oncotherapy.[154]"
    }, {
      "heading" : "2.5.2. Biosensing",
      "text" : "Because of the larger specific surface area, higher edge concentration and more unique electronic properties compared with their bulk counterparts, NPs have been extensively investigated in biosensing.[155] Among them, noble metal NPs are one of the most broadly explored categories because of their exceptional properties. Localized surface plasmon resonance (LSPR) is the most prominent features of noble metal NPs for biosensing. Additionally, LSPR can be controlled by regulating sizes, shapes and surface functionalization of the NPs.[156] Lopez-Lorente et al. designed a stainless-steel continuous-flow microfluidic chip to generate AuNPs.[157] By precise control over the concentration of gold precursor, the flow rates and the reaction temperature, the size of resultant AuNPs and the wavelength of LSPR peak could be well-tuned. In addition,\nthese NPs were demonstrated to be a good candidate to perform surface enhanced infrared absorption of biomolecules existing in solution, thereby could be used as biosensors. Lazarus et al. used a droplet-based microfluidic chip in tandem with an imidazolium-based ionic liquid to generate AuNPs with excellent spherical morphology and a mean diameter of about 4.38 nm, as determined by TEM analysis (Figure 5c). The results of UV–vis spectra showed that the AuNPs suspension had relatively narrow surface plasmon bands, which indicated their potential values in acting as biosensors.[158]\nComposite NPs with metal-rich shells have also been synthesized for biosensing applications. Visaveliya et al. used a droplet-based microfluidic chip to generate poly(methyl methacrylate) (PMMA)-poly (diallyldimethyl ammonium chloride) (PDADMAC)/Au nanoassemblies.[159] The copolymer NPs provided huge specific area for efficient absorption of AuNPs, while the metal-rich shells exhibited high LSPR upon UV–vis light irradiation and enhanced Raman scattering sensing. Thus, these resultant NPs with core–shell structures could be applied for the detection of various molecules. In another study, Rahman et al. specially designed a PDMS-based parallel-flow microfluidic chip to cover silica NPs with a thin shell of AuNPs (Figure 5d).[160] The core–shell nanocomposites were synthesized by introducing the diffusion of the CO airflow into the aqueous droplets generated in the microchip. By simply regulating the dosage of CO, the flow rates of reactive agents, the relative concentrations of Au ions and silica particles, the extent of Au coverage on silica NPs and the plasmon resonances could be tuned accurately, which was an significant feature for their future applications in biosensing.\nAs the nature of most biomedical samples is liquid, the NPs-based biosensors must be combined with appropriate fluid delivery platform. Microfluidic system can also provide an excellent platform to expand the application value of sensors, because of its ability to manipulate small-volume fluid in the micron scale. For example, Zheng et al. designed a microfluidic chip to facilitate the mixing between AuNPs and detection sample, and the color change of AuNPs aggregation could be easily captured for determining the concentration of the target bacteria.[161] In another study, SadAbadi et al. proposed an in-situ method for first generation and then integration of AuNPs in a microfluidic chip, and the integrated system was demonstrated to have application potentials in clinical detection of protein.[162] The reported advantages offered by microfluidics-based sensing platform include rapid processing procedure, reduced reagent consumption, eliminated cross contamination and enhanced detection efficiency. In addition, the integration strategy of NPs-based biosensors with microfluidics can also enable automated, miniaturized and portable systems, which meet with the direction of lab-on-a-chip development."
    }, {
      "heading" : "2.5.3. Bioimaging",
      "text" : "Owing to the stable physical and chemical properties, resistance to in vivo process of catabolism, nontoxicity and favorable dispersibility in biological environment, various kinds of NPs have been extensively applied for fluorescent imaging.[163]\nSmall 2019, 1901943\n1901943 (11 of 19)\nwww.advancedsciencenews.com\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim\nwww.small-journal.com\nFluorescent dye-doped silica NPs are one of the most common agents to be used in bioimaging. Organic, metallic and metalorganic fluorophores can be easily doped on the surface of silica NPs, with a wide range of emission wavelengths. For example, Sreejith et al. proposed a single-phase microfluidic chip combined with acoustic streaming to produce allenamide-thiol link on the surface of silica NPs.[164] This microfluidic approach allowed for generation of monodispersed and biocompatible NPs under aqueous conditions, and surface coupling of functional groups with a high efficiency. In addition, the conjugation process could be precisely controlled using the applied actuation of acoustic wave, which improved the application value of fluorescent dye-doped silica NPs in bioimaging.\nQDs have emerged as a promising fluorescent label for bioimaging research owing to their specific photophysical properties. Compared to fluorescent dye-doped imaging agents, they show a negligible tendency for photobleaching, because the fluorescence of these NPs origins from a photonic quantum effect. In addition, the colors of emission are tunable from UV to NIR region by controlling the size or composition of QDs.[165] Kikkeri et al. proposed a single-phase microfluidic chip for the generation of carbohydrate-modified CdSe and CdTe NPs.[166] Owing to the high surface-to-volume ratio of the reaction flow in microchannels, the functionalized QDs could be generated under efficient mixing and low temperature. And the monodispersed QDs with emission maxima ranging from 480 to 598 nm could serve as a kind of excellent bioimaging agents. In another well-designed experiment, the continuousflow microfluidic chip was introduced to synthesize ZnSe/ ZnS core–shell QDs.[167] The precursor solutions was efficiently mixed in the mixing zone of the microchip, and then transferred to the heating zone for the formation of QDs with core–shell structure. Similarly, the resultant QDs had a narrow size distribution with an average diameter of about 3.88 nm, and the shell structure improved their stability and emission enhancement.\nThe MRI technique based on the principles of nuclear magnetic resonance has grown as a powerful tool in clinical diagnostics, especially for soft tissues. The design of superparamagnetic NPs as signal-enhancing agents has been extensively investigated to generate image contrast (bright/dark) for MRI diagnosis.[168] Jung et al. introduced a flow-focusing microfluidic chip to generate droplets which encapsulated E. coli cells and metal sources for synthesizing FeMn NPs (Figure 5e).[95] These droplet-based biogenic NPs had a narrow size distribution of (5.17 ± 0.24) nm, which was threefold improved than the off-chip-based NPs. Furthermore, the resultant FeMn NPs was unsaturated without losing the magnetic properties, indicating their promising values as ideal enhancement agents for MRI. A new microfluidic chip with a double-loop micromixer has been developed by Lee et al. to synthesize iron oxide NPs (Figure 5f).[169] Owing to the enhanced mixing efficiency, the microfluidic technology could successfully generate uniform iron oxide NPs within a short time period. In addition, these resultant NPs exhibited superparamagnetic behavior, as evidenced by the zero coercivity and remanence in the magnetization curve, and thus could be used in magnetic bead-enhanced contrast bioimaging."
    }, {
      "heading" : "3. Microfluidic Spinning of NFs",
      "text" : "NFs-based materials have emerged as excellent candidates in biomedical applications because of their capability to resemble the morphological and physiological characteristics of native microenvironment in vivo.[170] Various spinning techniques have been introduced to prepare NFs, which mainly including wet-, dry-, melt-, and electrospinning. Standard wet-, dry-, and melt-spinning are all solution-based processing techniques which consist of a polymer solution, a spinneret and a collector. Before the spinning operation, the polymers must be first converted into a liquid form. Then, a syringe pump was used to extrude the polymer solution through a spinneret. Finally, the solid fibers can be continuously generated after chemical reaction or solvent evaporating.[171] Unique from these approaches is electrospinning, in which NFs are generated by electrically charging a viscous precursor solution. In a basic electrospinning setup, a voltage supplier, a metal needle connected to a syringe and a metal collector are three key compositions. A high voltage applied at the needle make it possible for inducing charges on the free solutions containing in the syringe. Then, the electrostatic force pushes the liquid droplets to erupt from the tip of the needle and accelerate toward the collector. As the solvent evaporates rapidly, the solid fibers with nanoscale diameters are generated with large output.[172] Though these spinning techniques are prevalent and popular, they are limited by the lack of available materials compatible with the process, organic solvents residue on the fiber surface and nonuniformity caused from unstable production environment. In addition, the extreme temperature, large shear or high voltage existing in these procedures have prevented the generation of cell-laden or bioactive-laden fibers, and denatured sensitive components when natural polymers are used. Therefore, these conventional methods have restricted the application value of NFs in biomedical areas.\nMicrofluidic spinning, a technique inspired by the natural process of fiber-formation in spiders or silkworms, has recently shown great potentials as a novel platform for producing NFs with more flexibility and reproducibility.[77,173] The accurate control over fluid flows with diversity of microchannel geometries has enabled the production of uniform, monodisperse NFs with tailored size, shape, material composition and novel constructs that better mimic human tissues. Most importantly, because of the benign reaction conditions, the biological functions of sensitive components can be well-conserved, and the living cells can be directly loaded into NFs with high viability.[60,174] Here, we offer an overview of the microfluidic NFs using either synthetic or natural materials, and their applications in biomedical areas, after a brief description of fabrication mechanism underlying microfluidic systems."
    }, {
      "heading" : "3.1. Basic Fabrication Mechanism",
      "text" : "The first and fundamental step of microfluidic spinning is generating coaxial flows consisting of a core and sheath fluid phase, which is accomplished by employing a specially designed microfluidic chip.[34,175] The core flow is pumped into the inner channel of the microchip, while the sheath flow pumped into\nSmall 2019, 1901943\n1901943 (12 of 19)\nwww.advancedsciencenews.com\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim\nwww.small-journal.com\nthe outer channel. Afterward, the coaxial laminar flows are formed in which the core flow is surrounded by the sheath flow from all directions. Under the microscale dimension, the Reynolds number is small, which facilitates the stable formation of laminar flows in the microfluidic device without turbulence. After converting the core flow into solid state, the polymeric fibers can be continuously generated in the microchannel. Both synthetic polymers (e.g., polyurethane, poly(ethylene glycol) diacrylate, and PLGA) and natural polymers (e.g., alginate, hyaluronic acid, and silk fibroin (SF)) can be used by microfluidics to fabricate fibers. The solidification methods must be selected carefully according to the precursor materials, which generally include in situ photo-polymerization, ionic or chemical crosslinking, self-assembly and solvent exchange.[176,177]"
    }, {
      "heading" : "3.2. Microfluidic NFs from Synthetic Materials",
      "text" : "Because of the strong mechanical properties with controllable degradation rates, NFs generated from synthetic materials have been extensively explored in repairing tissues which need to bear pressure, such as abdominal walls, heart valves and blood vessels.[178] An important branch of microfluidic fabrication is fabricating NFs to compete with more popular electrospinning method. In order to overcome the current limitations of electrospinning and generate NFs with uniform size and shape, Thangawng et al. introduced a specific microfluidic chip to fabricate PMMA NFs (Figure 6a).[179] Owing to the diagonal grooves or chevron-shaped grooves designed in the microfluidic chips, the core flow could be compressed by the surrounding fluids and kept away from the walls of the microchannels. Using this sheath-flow microfluidic chip, the diameter of the resulting PMMA fibers was decreased to about 300 nm, and could be tuned by simply changing the flow rates of core and sheath flow. In another study, Puigmartí-Luis et al. used microfluidic technology to generate a special type of NFs by self-assembling of Cu2+ and amino acid aspartate (Asp) under laminar flow conditions.[180] Owing to the scaling-down dimensions inside the microfluidic chip, the generation of long Cu2+-Asp NFs has been promoted dramatically. The TEM image of the resulting NFs was shown in Figure 6b, the diameters of these fibers ranged from 10 to 50 nm. Therefore, compared with complicated and time-consuming traditional methods, microfluidics is demonstrated to be more simplified and time-saving.\nIn a more common case, the microfluidic chip was introduced to facilitate the electrospinning of polymeric NFs with complex components and structures. For example, Zhang et al. produced a series of PLGA NFs with various gradients by combining a microfluidic chip with an electrospinning nozzle.[181] As shown in Figure 6c, the PLGA and another solution (gelatin, NPs or other bioactive molecules) was first pumped into a two-inlet microfluidic chip respectively, then well blended in the microchannel, and finally electrospun from a nozzle. This combined approach allowed for the production of PLGA NFs with different concentrations of another component by simply altering the flow rates, endowed the NFs with specific chemical and physical properties, thus showed advantages over previous methods because of its versatility and controllability. In another example, the similar combined method was introduced by\nSrivastava et al. to successfully fabricate poly(vinylpyrrolidone) (PVP) and PVP/polypyrrole (Ppy) composite NFs.[182] The NFs could be generated continuously and the average diameter was about 100 nm, which could be controlled by the polymer concentration, feed rates and applied voltage. In addition, the multichannel chip also provided the benefit of electrospinning NFs from multiple jets simultaneously. On the basis of this study, they further prepared hollow NFs composed of PVP and titania (TiO2) and core–shell Ppy-PVP NFs using coaxial microfluidic electrospinning device. Both the hollow and core–shell NFs were uniform with average diameters of about 100 and 250 nm, respectively.[183]"
    }, {
      "heading" : "3.3. Microfluidic NFs from Natural Materials",
      "text" : "In the past, most studies were only focused on synthetic materials due to their easy operation. However, synthetic materials usually exhibit a certain toxicity because of the presence of chemical components that are harmful to our health. Natural materials can avoid this problem, because they are mainly composed of biocompatible polysaccharides or proteins, which are also the main components of extracellular matrices (ECMs).[184] Compared to electrospinning, microfluidics is more preferable for manufacturing natural materials, because of the mild spinning environment and the ability to spin natural polymers without using synthetic polymers as aids or toxic solvents. In addition, sensitive cells and bioactives can be loaded into NFs undamaged by microfluidics because all encapsulation processes were in aqueous surroundings.\nAlginate is the one of most commonly used natural materials in microfluidic spinning, because of its easy and rapid gelation reaction. Chae et al. proposed a microfluidic method for generation of ultrathin alginate fibers with a highly ordered structure of nanostrands.[176] As shown in Figure 6d, the spinning was accomplished by introducing the alginate aqueous solution and isopropyl alcohol (IPA) solvent as the core and sheath fluid respectively. Under the dehydration effect provided by the IPA sheath flow, the polymer chains of alginate in the core flow self-aggregated, and a crystal-like ordered fiber with aligned nanostrands was created. This flow-focusing method accelerated the polymer chains to self-align along the direction of flow to form crystal-like ordered fibrous structures, with diameters ranging from 70 to 20 µm. Using similar principles, Numata et al. proposed a Y-shaped microfluidic chip to create NFs from a natural polysaccharide, schizophyllan (SPG).[185] As shown in Figure 6e, distilled water and SPG dissolved in dimethyl sulfoxide (DMSO) were pumped into the two inlets of microfluidic chip respectively, and formed a liquid–liquid interface between the two solutions after they encountered at the Y-junction. By tuning the flow rates and the concentration of SPG, polysaccharide NFs could be generated owing to the inherent self-assembling capability of SPG."
    }, {
      "heading" : "3.4. Biomedical Applications of NFs from Microfluidics",
      "text" : "NFs are a promising kind of 1D materials, which can be bundled, weaved or knotted into higher-ordered networks for a wide range of advanced applications.[186] The NF-based strategy has\nSmall 2019, 1901943\n1901943 (13 of 19)\nwww.advancedsciencenews.com\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim\nwww.small-journal.com\nSmall 2019, 1901943\n1901943 (14 of 19)\nwww.advancedsciencenews.com\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim\nwww.small-journal.com\npromising potentials in creating artificial tissues because the complex organizational structures inside human body involve various types of fibrous constructs such as blood vessels, neural pathways and muscle fibers.[187] The homogeneous fibers from microfluidic spinning have been demonstrated as an ideal biomaterial in tissue engineering, because of their large surface area, specific interfacial cues, ease of functionalization, flexible mechanical strengths, ability to encapsulate cells with high viability and control over the distribution of cells.[77]"
    }, {
      "heading" : "3.4.1. Cell Encapsulation",
      "text" : "Successful construction of fiber-shaped cellular assemblies can greatly contribute to the creation of organoids in vitro. However, the fabrication of fibers encapsulating cellular components lacks of an mature technology, and is embarrassed by handling sensitive cells that require benign environment.[17,34] Recent developments in microfluidics have shown great promise in fabricating fiber-shaped building blocks and various types of hierarchical structures similar to fibrous tissues in human body. For example, with the aid of photolithographically fabricated microfluidic devices and the use of photo-cross-linkable methacrylated alginate, Wei et al. realized continuous generation of fibers with encapsulation of endothelial cells and osteoblast cells.[188] Because of the mild manufacturing process in microfluidic chip and favorable biocompatibility afforded by alginate hydrogel, the enhanced vasculogenic and osteogenic expression were observed, which indicated the high viability and activity of encapsulated cells. In another study, Lee et al.\nSmall 2019, 1901943\n1901943 (15 of 19)\nwww.advancedsciencenews.com\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim\nwww.small-journal.com\ndesigned a coaxial microfluidic device to produce composite fibers from alginate and chitosan hydrogels, and encapsulate HepG2 cells into the fibers at the same time (Figure 7a). The LIVE/DEAD assay confirmed that the encapsulated HepG2 cells kept a high survival rate for more than 7 d.[189] Similarly, Cheng et al. introduced a Y-shaped PDMS-based microfluidic device to generate cell-laden hydrogel fibers, using the SF/alginate solution mixed with L929 fibroblast cells as the core flow, the CaCl2 aqueous solution as the sheath flow (Figure 7b).[190] The results of LIVE/DEAD assay showed that cells in the SF/ alginate fibers remained alive with a high viability for a long period (>12 d). Therefore, the microfluidic approach may play an important role in creating functional building blocks, and have advantages in tissue engineering and repairing of complex, large tissue defects."
    }, {
      "heading" : "3.4.2. Cell Alignment",
      "text" : "It has been widely identified that orienting cells along fiber directions can induce the secretion and deposition of anisotropic ECMs, which is important for the regeneration of organized tissues, such as ligaments, skeletal muscles and peripheral nerves.[191] By manipulating the distribution of electric field, the electrospinning techniques have been developed to generate fibers with demanded orientation.[192] The rotating mandrel was one of the most popular collectors to control over the alignment of electrospun fibers. However, because the syringe tip sprays polymer solutions all over the mandrel, the alignment degree of produced fibers is very poor. To overcome the dilemma, Haynl et al. introduced a flow-focusing microfluidic chip to produce collagen fibers (Figure 7c).[193] By collecting the collagen fibers using a rotating spool, and matching the flow rates in microfluidic chip and the collection rates of rotating spool, highly ordered fibers could be obtained continuously. Cell culture tests using the neuronal cell line NG108-15 showed that, the cells migrated directionally along the longitudinal fiber axes. All promising results indicated that these resultant collagen fibers could be potentially useful in guiding axonal growth and repairing peripheral nerve defects. Using the PDMS-based soft lithography, Kang et al. specially designed a microfluidic device with microgrooves to generate alginate fibers with longitudinally grooves.[194] From the fluorescent and scanning electron microscope (SEM) images of the cells adhered to the surface of grooved fibers, it was found that they migrated along the same directions of the grooves on fibers. Therefore, the microfluidicpatterned fantastic fibers could align various types of cells, such as angioblast cells and myoblast cells, and has great potential value in regeneration of blood vessels and skeletal muscles."
    }, {
      "heading" : "3.4.3. Wound Healing",
      "text" : "Wound dressings fabricated from fibers possess unique properties for promoting the healing process. Their similar morphology with ECMs can facilitate cell adhesion and proliferation. Their high surface-to-volume ratio and porous structure is convenient for the exchange of oxygen, water and nutrients, as well as the removal of metabolic waste. In addition,\nanti-infective agents or growth factors can be encapsulated into these fibers, which further reinforce the repairing ability of these dressings.[195,196] Yu et al. generated copper- or zincMOF laden alginate fibers using a double co-axial microfluidic device for wound healing (Figure 7d).[197] The composition, size and morphology of the hybrid fibers could be tuned by simply adjusting the flow rates, which determined the release kinetics of the encapsulated MOF. After implantation in an murine model of infected full-thickness skin defect, the copper-MOF laden fibers showed their anti-infection ability, and the zincMOF laden fibers showed their oxidation resistance, both of them could provide a better environment for wound healing. Hao et al. specially designed a spiral-shaped microfluidic chip to generate mesoporous silica NFs (MSNFs) (Figure 7e).[198] The average diameter and aspect ratio of the resultant fibers was about 130 nm and 12 respectively, and these properties could be precisely controlled by simply altering the flow rates and concentrations of the reactants. Owing to the specific mesoporous structures on MSNFs, a variety of therapeutic cargos could be absorbed into the NFs with a high loading efficiency. When loading with AgNPs, the MSNFs possessed of antibacterial activity and could reduce the risk of wound infection. When loading with growth factors, the MSNFs could further promote tissue repairing. All these results indicated that the microfluidic fibers were ideal to function as wound dressings and meanwhile released bioactives to improve wound healing."
    }, {
      "heading" : "4. Conclusions and Perspective",
      "text" : "The most important part of this review includes examples of NPs and NFs that were synthesized using microfluidic devices, and their biomedical applications. Because of the theoretical research and technological innovations, microfluidic technology has developed as an economical, simple and powerful tool for the synthesis of NMs with high monodispersity and reproducibility, thus advancing their functions in drug delivery, biosensing, bioimaging and tissue engineering. However, several challenges should be dedicated to promote the microfluidics becoming an irreplaceable tool for NMs synthesis.\nFirst, although the generation of uniform NMs by microfluidics is experiencing rapid development at the proof-ofconcept stage, the translation of this technology from academic research to industrial and clinical practice still faces several critical challenges, and one of the greatest hurdles is the mass production. Several investigations on the scale-up of microfluidic platforms have been reported, and parallelization is one of the most common strategies which can improve the quantity of NMs from microgram to kilogram scale.[102,199] Another aspect to increase production rate is developing microfluidic devices that can withstand high-pressure operation. As the microscale dimension of the chips, the pressure inside the microchannels rises dramatically as a function of the increasing flow rate. Therefore, to obtain high throughput production of NMs, the device materials, the processing methods and the package approaches of different modules should be further investigated.\nSecond, another direction of future research will be the integration of different steps of NMs development (for example,\nSmall 2019, 1901943\n1901943 (16 of 19)\nwww.advancedsciencenews.com\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim\nwww.small-journal.com\nSmall 2019, 1901943\nNMs formation, modification and purification) into a sequential flow process. Through unremitting efforts, it is convinced that an integrated microfluidic chip will appear soon to synthesize advanced NMs with a high purity directly from raw materials. In addition, a more-integrated system combined with in situ monitoring techniques deserves particular attention, which can optimize the synthetic parameters at any time through an immediate feedback control. With these improvements, microfluidics will be developed as a powerful approach to generate NMs for different applications.\nThird, besides the request for homogeneity, demanded nanostructure is another significant consideration when synthesizing NMs. The microfluidic-based systems have provided a new strategy regarding the fabrication of NMs with flexible structures. However, compared to the microscale materials, the diversity and functionality of the microfluidics-derived NMs are still lacking. Even though several studies have used multiphase microfluidic systems to successfully synthesize complex NMs, it is time-consuming and technically difficult especially when fabricating multichannel microfluidic chip. Therefore, the microfluidic process is usually tedious to synthesize NMs with complicated constructions which are highly desired for practical applications. Fortunately, the development of 3D printing may offer a solution to this dilemma. The additive manufacturing technique can translate 3D digital designs into physical models through layer-by-layer construction. Compared with lithography-based methods which required multistep and labor-intensive process, 3D printing enables fabrication of microfluidic chips with defined cross sections in a single step. Since the resolution of 3D printer has already downscaled to nanoscale dimension, structural complexity is no longer a concern, and the functionality of microfluidic chips can be greatly improved for synthesizing advanced NMs. In addition, using this technology instead of traditional methods, the flexible design and preparation process of microfluidic chips is significantly simplified, which increases the accessibility to microfluidic technologies for much more research labs and accelerates the innovation in the field of microfluidic NMs.[200,201]\nIn conclusion, the development of microfluidic technology in nanofabrication brings exciting opportunities to expand the biomedical application of NMs. We do believe that with further investigations and optimizations, the microfluidics will enable practicable mass production of high-value NMs with specific structures and advanced functions, which is difficult to achieve in other approaches."
    }, {
      "heading" : "Acknowledgements",
      "text" : "This work was supported by the National Key Research and Development Program of China (Grant No. 2017YFA0700404), the National Natural Science Foundation of China (Grant Nos. 21473029 and 51522302), the Scientific Research Foundation of Southeast University, and the Scientific Research Foundation of Graduate School of Southeast University.\nConflict of Interest The authors declare no conflict of interest.\nKeywords biomedical, microfluidics, nanofibers, nanomaterials, nanoparticles\nReceived: April 17, 2019 Revised: June 9, 2019\nPublished online:\n[1] V. Biju, Chem. Soc. Rev. 2014, 43, 744. [2] F. Peng, Y. Y. Su, Y. L. Zhong, C. H. Fan, S. T. Lee, Y. He,\nAcc. Chem. Res. 2014, 47, 612. [3] H. Kim, S. Beack, S. Han, M. Shin, T. Lee, Y. Park, K. S. Kim,\nA. K. Yetisen, S. H. Yun, W. Kwon, S. K. Hahn, Adv. Mater. 2018, 30, 1701460. [4] D. Chimene, D. L. Alge, A. K. Gaharwar, Adv. Mater. 2015, 27, 7261. [5] A. P. Blum, J. K. Kammeyer, A. M. Rush, C. E. Callmann,\nM. E. Hahn, N. C. Gianneschi, J. Am. Chem. Soc. 2015, 137, 2140. [6] C. F. Markwalter, A. G. Kantor, C. P. Moore, K. A. Richardson,\nD. W. Wright, Chem. Rev. 2019, 119, 1456. [7] S. Kim, J. M. Kim, J. E. Park, J. M. Nam, Adv. Mater. 2018, 30,\n1704528. [8] K. S. Krishna, Y. H. Li, S. N. Li, C. S. S. R. Kumar, Adv. Drug Delivery\nRev. 2013, 65, 1470. [9] N. Lee, D. Yoo, D. Ling, M. H. Cho, T. Hyeon, J. Cheon, Chem. Rev.\n2015, 115, 10637. [10] A. R. Kirtane, J. Panyam, Nat. Nanotechnol. 2013, 8, 805. [11] Z. Fan, L. Sun, Y. Huang, Y. Wang, M. Zhang, Nat. Nanotechnol.\n2016, 11, 388. [12] E. J. Keliher, Y. X. Ye, G. R. Wojtkiewicz, A. D. Aguirre, B. Tricot,\nM. L. Senders, H. Groenen, F. Fay, C. Perez-Medina, C. Calcagno, G. Carlucci, T. Reiner, Y. Sun, G. Courties, Y. Iwamoto, H. Y. Kim, C. H. Wang, J. W. Chen, F. K. Swirski, H. Y. Wey, J. Hooker, Z. A. Fayad, W. J. M. Mulder, R. Weissleder, M. Nahrendorf, Nat. Commun. 2017, 8, 14064. [13] G. Sahay, W. Querbes, C. Alabi, A. Eltoukhy, S. Sarkar, C. Zurenko, E. Karagiannis, K. Love, D. Chen, R. Zoncu, Y. Buganim, A. Schroeder, R. Langer, D. G. Anderson, Nat. Biotechnol. 2013, 31, 653. [14] S. Li, J. Huang, Adv. Mater. 2016, 28, 1143. [15] Y. J. Kim, M. Ebara, T. Aoyagi, Angew. Chem., Int. Ed. Engl. 2012,\n51, 10537. [16] Y. Wu, L. Wang, B. Guo, P. X. Ma, ACS Nano 2017, 11, 5646. [17] Z. Zhang, J. Hu, P. X. Ma, Adv. Drug Delivery Rev. 2012, 64, 1129. [18] M. S. Lee, T. Ahmad, J. Lee, H. K. Awada, Y. Wang, K. Kim, H. Shin,\nH. S. Yang, Biomaterials 2017, 124, 65. [19] E. K. Lim, T. Kim, S. Paik, S. Haam, Y. M. Huh, K. Lee, Chem. Rev.\n2015, 115, 327. [20] P. D. Howes, S. Rana, M. M. Stevens, Chem. Soc. Rev. 2014, 43,\n3835. [21] J. Q. Chen, C. Y. Ning, Z. N. Zhou, P. Yu, Y. Zhu, G. X. Tan,\nC. B. Mao, Prog. Mater. Sci. 2019, 99, 1. [22] A. C. A. Wan, J. Y. Ying, Adv. Drug Delivery Rev. 2010, 62, 731. [23] S. Hassan, G. Prakash, A. B. Ozturk, S. Saghazadeh, M. F. Sohail,\nJ. Seo, M. Dockmeci, Y. S. Zhang, A. Khademhosseini, Nano Today 2017, 15, 91. [24] G. T. Zan, Q. S. Wu, Adv. Mater. 2016, 28, 2099. [25] S. Mitragotri, D. G. Anderson, X. Y. Chen, E. K. Chow, D. Ho,\nA. V. Kabanov, J. M. Karp, K. Kataoka, C. A. Mirkin, S. H. Petrosko, J. Shi, M. M. Stevens, S. Sun, S. Teoh, S. S. Venkatraman, Y. Xia, S. Wang, Z. Gu, C. Xu, ACS Nano 2015, 9, 6644. [26] Y. Gao, J. Lim, S. H. Teoh, C. Xu, Chem. Soc. Rev. 2015, 44, 6306. [27] P. M. Valencia, O. C. Farokhzad, R. Karnik, R. Langer, Nat. Nano-\ntechnol. 2012, 7, 623.\n1901943 (17 of 19)\nwww.advancedsciencenews.com\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim\nwww.small-journal.com\nSmall 2019, 1901943\n[28] F. Y. Zheng, F. F. Fu, Y. Cheng, Y. J. Zhao, Z. Z. Gu, Small 2016, 12, 2253. [29] H. J. Kwon, K. Shin, M. Soh, H. Chang, J. Kim, J. Lee, G. Ko, B. H. Kim, D. Kim, T. Hyeon, Adv. Mater. 2018, 30, 1704290. [30] Y. Zhang, J. Tu, D. Wang, H. Zhu, S. K. Maity, X. Qu, B. Bogaert, H. Pei, H. Zhang, Adv. Mater. 2018, 30, 1703658. [31] P. M. Valencia, E. M. Pridgen, M. Rhee, R. Langer, O. C. Farokhzad, R. Karnik, ACS Nano 2013, 7, 10671. [32] P. Retif, S. Pinel, M. Toussaint, C. Frochot, R. Chouikrat, T. Bastogne, M. Barberi-Heyob, Theranostics 2015, 5, 1030. [33] L. Shang, Y. Cheng, Y. Zhao, Chem. Rev. 2017, 117, 7964. [34] Y. Yu, L. Shang, J. Guo, J. Wang, Y. Zhao, Nat. Protoc. 2018, 13,\n2557. [35] M. Zou, J. Wang, Y. Yu, L. Sun, H. Wang, H. Xu, Y. Zhao, ACS Appl.\nMater. Interfaces 2018, 10, 34618. [36] X. Zhao, Y. Liu, Y. Yu, Q. Huang, W. Ji, J. Li, Y. Zhao, Nanoscale\n2018, 10, 12595. [37] X. Zhao, Z. Chen, Y. Liu, Q. Huang, H. Zhang, W. Ji, J. Ren, J. Li,\nY. Zhao, Adv. Healthcare Mater. 2018, 7, 1801005. [38] J. Wu, T. Kong, K. W. Yeung, H. C. Shum, K. M. Cheung, L. Wang,\nM. K. To, Acta Biomater. 2013, 9, 7410. [39] S. N. Bhatia, D. E. Ingber, Nat. Biotechnol. 2014, 32, 760. [40] F. Bian, H. Wang, L. Sun, Y. Liu, Y. Zhao, J. Mater. Chem. B 2018,\n6, 7257. [41] T. Kong, J. Wu, K. W. Yeung, M. K. To, H. C. Shum, L. Wang,\nBiomicrofluidics 2013, 7, 44128. [42] Y. Liu, Q. Huang, J. Wang, F. Fu, J. Ren, Y. Zhao, Sci. Bull. 2017, 62,\n1283. [43] J. Wang, Y. Cheng, Y. Yu, F. Fu, Z. Chen, Y. Zhao, Z. Gu, ACS Appl.\nMater. Interfaces 2015, 7, 27035. [44] B. L. Wang, A. Ghaderi, H. Zhou, J. Agresti, D. A. Weitz, G. R. Fink,\nG. Stephanopoulos, Nat. Biotechnol. 2014, 32, 473. [45] T. S. Kaminski, P. Garstecki, Chem. Soc. Rev. 2017, 46, 6210. [46] Q. Feng, L. Zhang, C. Liu, X. Li, G. Hu, J. Sun, X. Jiang, Biomicro-\nfluidics 2015, 9, 052604. [47] J. Wang, M. Zou, L. Sun, Y. Cheng, L. Shang, F. Fu, Y. Zhao, Sci.\nChina Mater. 2017, 60, 857. [48] H. H. Shi, K. X. Nie, B. Dong, M. Q. Long, H. Xu, Z. C. Liu, Chem.\nEng. J. 2019, 361, 635. [49] S. Soleimani, M. M. Hasani-Sadrabadi, F. S. Majedi,\nE. Dashtimoghadam, M. Tondar, K. I. Jacob, Colloids Surf., B 2016, 145, 802. [50] Y. Zhao, Y. Cheng, L. Shang, J. Wang, Z. Xie, Z. Gu, Small 2015, 11, 151. [51] L. Shang, Y. Wang, Y. Yu, J. Wang, Z. Zhao, H. Xu, Y. Zhao, J. Mater. Chem. A 2017, 5, 15026. [52] S. S. Lee, H. J. Seo, Y. H. Kim, S. H. Kim, Adv. Mater. 2017, 29, 1606894. [53] J. Ma, S. M. Y. Lee, C. Yi, C. W. Li, Lab Chip 2017, 17, 209. [54] J. Wang, L. Shang, Y. Cheng, H. Ding, Y. Zhao, Z. Gu, Small 2015,\n11, 3890. [55] L. Shang, Y. Cheng, J. Wang, H. Ding, F. Rong, Y. Zhao, Z. Gu,\nLab Chip 2014, 14, 3489. [56] L. Shang, Y. Cheng, J. Wang, Y. Yu, Y. Zhao, Y. Chen, Z. Gu,\nLab Chip 2016, 16, 251. [57] Y. Yu, L. Shang, W. Gao, Z. Zhao, H. Wang, Y. Zhao, Angew. Chem.,\nInt. Ed. Engl. 2017, 129, 12295. [58] Y. Yu, F. Fu, L. Shang, Y. Cheng, Z. Gu, Y. Zhao, Adv. Mater. 2017,\n29, 1605765. [59] L. Shang, F. Fu, Y. Cheng, Y. Yu, J. Wang, Z. Gu, Y. Zhao, Small\n2017, 13, 1600286. [60] Y. Cheng, F. Zheng, J. Lu, L. Shang, Z. Xie, Y. Zhao, Y. Chen, Z. Gu,\nAdv. Mater. 2014, 26, 5184. [61] Y. Cheng, C. Zhu, Z. Xie, H. Gu, T. Tian, Y. Zhao, Z. Gu, J. Colloid\nInterface Sci. 2014, 421, 64.\n[62] L. Shang, F. Shangguan, Y. Cheng, J. Lu, Z. Xie, Y. Zhao, Z. Gu, Nanoscale 2013, 5, 9553. [63] H. Gu, F. Rong, B. Tang, Y. Zhao, D. Fu, Z. Gu, Langmuir 2013, 29, 7576. [64] L. J. Pan, J. W. Tu, H. T. Ma, Y. J. Yang, Z. Q. Tian, D. W. Pang, Z. L. Zhang, Lab Chip 2018, 18, 41. [65] X. He, A. Lu, J. Cheng, J. Chen, Q. Song, W. Liu, C. Chen, Nano 2017, 12, 1730002. [66] J. Ahn, J. Ko, S. Lee, J. Yu, Y. Kim, N. L. Jeon, Adv. Drug Delivery Rev. 2018, 128, 29. [67] M. Maeki, N. Kimura, Y. Sato, H. Harashima, M. Tokeshi, Adv. Drug Delivery Rev. 2018, 128, 84. [68] J. M. Koehler, Nanotechnol. Rev. 2014, 3, 1. [69] Y. Liu, X. Jiang, Lab Chip 2017, 17, 3960. [70] X. Wang, J. Liu, P. Wang, A. deMello, L. Feng, X. Zhu, W. Wen,\nR. Kodzius, X. Gong, Genes 2018, 9, 283. [71] H. H. Shi, Y. Xiao, S. Ferguson, X. Huang, N. Wang, H. X. Hao,\nLab Chip 2017, 17, 2167. [72] L. Capretto, D. Carugo, S. Mazzitelli, C. Nastruzzi, X. Zhang,\nAdv. Drug Delivery Rev. 2013, 65, 1496. [73] L. L. Lazarus, C. T. Riche, B. C. Marin, M. Gupta, N. Malmstadt,\nR. L. Brutchey, ACS Appl. Mater. Interfaces 2012, 4, 3077. [74] D. Liu, S. Cito, Y. Zhang, C. F. Wang, T. M. Sikanen, H. A. Santos,\nAdv. Mater. 2015, 27, 2298. [75] C. G. Koh, X. Zhang, S. Liu, S. Golan, B. Yu, X. Yang, J. Guan,\nY. Jin, Y. Talmon, N. Muthusamy, K. K. Chan, J. C. Byrd, R. J. Lee, G. Marcucci, L. J. Lee, J. Controlled Release 2010, 141, 62. [76] M. Zhang, W. Wang, R. Xie, X. Ju, Z. Liu, L. Jiang, Q. M. Chen, L. Chu, Particuology 2016, 24, 18. [77] Y. Jun, E. Kang, S. Chae, S. H. Lee, Lab Chip 2014, 14, 2145. [78] W. Li, L. Zhang, X. Ge, B. Xu, W. Zhang, L. Qu, C. H. Choi, J. Xu,\nA. Zhang, H. Lee, D. A. Weitz, Chem. Soc. Rev. 2018, 47, 5646. [79] L. A. Bawazer, C. S. McNally, C. J. Empson, W. J. Marchant,\nT. P. Comyn, X. Niu, S. Cho, M. J. McPherson, B. P. Binks, A. deMello, F. C. Meldrum, Sci. Adv. 2016, 2, 1600567. [80] T. Rossow, P. S. Lienemann, D. J. Mooney, Macromol. Chem. Phys. 2017, 218, 1600380. [81] Z. Farka, T. Juřík, D. Kovárř, L. Trnková, P. Skládal, Chem. Rev. 2017, 117, 9973. [82] W. Gao, Y. Chen, Y. Zhang, Q. Zhang, L. Zhang, Adv. Drug Delivery Rev. 2018, 127, 46. [83] L. Cheng, C. Wang, L. Z. Feng, K. Yang, Z. Liu, Chem. Rev. 2014, 114, 10869. [84] A. Gupta, S. Mumtaz, C. H. Li, I. Hussain, V. M. Rotello, Chem. Soc. Rev. 2019, 48, 415. [85] R. Thiruppathi, S. Mishra, M. Ganapathy, P. Padmanabhan, B. Gulyás, Adv. Sci. 2017, 4, 1600279. [86] E. Blanco, H. Shen, M. Ferrari, Nat. Biotechnol. 2015, 33, 941. [87] E. R. Zubarev, Nat. Nanotechnol. 2013, 8, 396. [88] F. Li, J. Lu, X. Kong, T. Hyeon, D. Ling, Adv. Mater. 2017, 29,\n1605897. [89] C. J. Serpell, J. Cookson, D. Ozkaya, P. D. Beer, Nat. Chem. 2011,\n3, 478. [90] G. C. Bleier, J. Watt, C. K. Simocko, J. M. Lavin, D. L. Huber,\nAngew. Chem., Int. Ed. Engl. 2018, 57, 7678. [91] A. E. Rawlings, J. P. Bramble, A. A. Tang, L. A. Somner,\nA. E. Monnington, D. J. Cooke, M. J. McPherson, D. C. Tomlinson, S. S. Staniland, Chem. Sci. 2015, 6, 5586. [92] T. Y. Hung, J. A. C. Liu, W. H. Lee, J. R. Li, ACS Appl. Mater. Interfaces 2019, 11, 4667. [93] M. Lu, A. Ozcelik, C. L. Grigsby, Y. Zhao, F. Guo, K. W. Leong, T. J. Huang, Nano Today 2016, 11, 778. [94] L. L. Li, X. Li, H. Wang, Small Methods 2017, 1, 1700140. [95] J. H. Jung, T. J. Park, S. Y. Lee, T. S. Seo, Angew. Chem., Int. Ed.\nEngl. 2012, 51, 5634.\n1901943 (18 of 19)\nwww.advancedsciencenews.com\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim\nwww.small-journal.com\nSmall 2019, 1901943\n[96] L. Zhang, Q. Feng, J. Wang, S. Zhang, B. Ding, Y. Wei, M. Dong, J. Y. Ryu, T. Y. Yoon, X. Shi, J. Sun, X. Jiang, ACS Nano 2015, 9, 9912. [97] J. P. Ma, C. W. Li, Sens. Actuators, B 2018, 262, 236. [98] E. Lallana, R. Donno, D. Magrì, K. Barker, Z. Nazir, K. Treacher,\nM. J. Lawrence, M. Ashford, N. Tirelli, Int. J. Pharm. 2018, 548, 530. [99] L. Uson, M. Arruebo, V. Sebastian, J. Santamaria, Chem. Eng. J. 2018, 340, 66. [100] N. Hao, Y. Nie, J. X. Zhang, Int. Mater. Rev. 2018, 63, 461. [101] H. Du Toit, T. J. Macdonald, H. Huang, I. P. Parkin, A. Gavriilidis,\nRSC Adv. 2017, 7, 9632. [102] P. Kunal, E. J. Roberts, C. T. Riche, K. Jarvis, N. Malmstadt,\nR. L. Brutchey, S. M. Humphrey, Chem. Mater. 2017, 29, 4341. [103] P. W. Dunne, A. S. Munn, C. L. Starkey, T. A. Huddle, E. H. Lester,\nPhilos. Trans. R. Soc., A 2015, 373, 20150015. [104] S. Seibt, P. Mulvaney, S. Förster, Colloids Surf., A 2019, 562, 263. [105] R. R. Hood, D. L. DeVoe, J. Atencia, W. N. Vreeland,\nD. M. Omiatek, Lab Chip 2014, 14, 2403. [106] S. Amrani, M. Tabrizian, ACS Biomater. Sci. Eng. 2018, 4, 502. [107] M. Ni, G. Tresset, C. Iliescu, Sens. Actuators, B 2017, 252, 458. [108] C. H. Kwak, S. M. Kang, E. Jung, Y. Haldorai, Y. K. Han, W. S. Kim,\nT. Yu, Y. S. Huh, J. Ind. Eng. Chem. 2018, 63, 405. [109] J. P. Martins, G. Torrieri, H A. Santos, Expert Opin. Drug Delivery\n2018, 15, 469. [110] D. E. Li, C. H. Lin, RSC Adv. 2018, 8, 16139. [111] L. Xu, J. Peng, M. Yan, D. Zhang, A. Q. Shen, Chem. Eng. Process.\n2016, 102, 186. [112] S. Duraiswamy, S. A. Khan, Small 2009, 5, 2828. [113] Y. F. Su, H. Kim, S. Kovenklioglu, W. Y. Lee, J. Solid State Chem.\n2007, 180, 2625. [114] J. I. Park, A. Saffari, S. Kumar, A. Günther, E. Kumacheva, Annu.\nRev. Mater. Res. 2010, 40, 415. [115] S. A. Khan, K. F. Jensen, Adv. Mater. 2010, 19, 2556. [116] Z. Wu, S. Yang, W. Wu, Nanoscale 2016, 8, 1237. [117] A. C. Anselmo, S. Mitragotri, AAPS J. 2015, 17, 1041. [118] D. Jaque, C. Richard, B. Viana, K. Soga, X. Liu, J. G. Sole, Adv. Opt.\nPhotonics 2016, 8, 1. [119] M. Hofmannamtenbrink, D. W. Grainger, H. Hofmann, Nanomedicine\n2015, 11, 1689. [120] J. A. Darr, J. Zhang, N. M. Makwana, X. Weng, Chem. Rev. 2017,\n117, 11125. [121] E. M. Chan, R. A. Mathies, A. P. Alivisatos, Nano Lett. 2003, 3, 199. [122] Y. Roig, S. Marre, T. Cardinal, C. Aymonier, Angew. Chem., Int. Ed.\nEngl. 2011, 50, 12071. [123] S. Gómez-de Pedro, M. Puyol, D. Izquierdo, I. Salinas,\nJ. M. de la Fuente, J. Alonso-Chamarro, Nanoscale 2012, 4, 1328. [124] S. Y. Tang, R. Qiao, S. Yan, D. Yuan, Q. Zhao, G. L. Yun, T. P. Davis,\nW. H. Li, Small 2018, 14, 1800118. [125] Y. Hu, Y. Li, F. J. Xu, Acc. Chem. Res. 2017, 50, 281. [126] E. Chiesa, R. Dorati, S. Pisani, B. Conti, G. Bergamini, T. Modena,\nI. Genta, Pharmaceutics 2018, 10, E267. [127] A. C. S. N. Pessoa, C. C. Sipoli, L. G. de la Torre, Lab Chip 2017,\n17, 2281. [128] K. Kim, D. H. Kang, M. S. Kim, K. S. Kim, K. M. Park, S. C. Hong,\nP. S. Chang, H. S. Jung, Colloids Surf., A 2015, 471, 86. [129] R. C. S. Bicudo, M. H. A. Santana, Chem. Eng. Sci. 2012, 84, 134. [130] V. P. Torchilin, Nat. Rev. Drug Discovery 2015, 4, 145. [131] A. D. Stroock, S. K. W. Dertinger, A. Ajdari, I. Mezic, H. A. Stone,\nG. M. Whitesides, Science 2002, 29, 647. [132] N. M. Belliveau, J. Huft, P. J. C. Lin, S. Chen, A. K. K. Leung,\nT. J. Leaver, A. W. Wild, J. B. Lee, R. J. Taylor, Y. K. Tam, C. L. Hansen, P. R. Cullis, Mol. Ther.–Nucleic Acids 2012, 1, e37. [133] H. Kim, J. Sung, Y. J. Chang, A. Alfeche, C. Leal, ACS Nano 2018, 12, 9196.\n[134] A. Jahn, S. M. Stavis, J. S. Hong, W. N. Vreeland, D. L. DeVoe, M. Gaitan, ACS Nano 2010, 4, 2077. [135] S. Libi, B. Calenic, C. E. Astete, C. Kumar, C. M. Sabliov, Nanotechnol. Rev. 2017, 6, 209. [136] L. H. Hung, S. Y. Teh, J. Jester, A. P. Lee, Lab Chip 2010, 10, 1820. [137] S. J. Zhang, C. I. Pelligra, X. D. Feng, C. O. Osuji, Adv. Mater. 2018, 30, 1705794. [138] R. Cheheltani, R. M. Ezzibdeh, P. Chhour, K. Pulaparthi, J. Kim,\nM. Jurcova, J. C. Hsu, C. Blundell, H. I. Litt, V. A. Ferrari, H. R. Allcock, C. M. Sehgal, D. P. Cormode, Biomaterials 2016, 102, 87. [139] X. Huang, R. J. Lee, Y. Qi, Y. Li, J. Lu, Q. Meng, L. Teng, J. Xie, Oncotarget 2017, 8, 96826. [140] M. X. Wu, Y. W. Yang, Adv. Mater. 2017, 29, 1606134. [141] M. Faustini, J. Kim, G. Y. Jeong, J. Y. Kim, H. R. Moon, W. S. Ahn,\nD. P. Kim, J. Am. Chem. Soc. 2013, 135, 14619. [142] L. Paseta, B. Seoane, D. Julve, V. Sebastián, C. Téllez, J. Coronas,\nACS Appl. Mater. Interfaces 2013, 5, 9405. [143] C. He, X. Duan, N. Guo, C. Chan, C. Poon, R. R. Weichselbaum,\nW. Lin, Nat. Commun. 2016, 7, 12499. [144] L. Zhang, Q. Feng, J. Wang, J. Sun, X. Shi, X. Jiang, Angew. Chem.,\nInt. Ed. Engl. 2015, 54, 3952. [145] S. Bochicchio, A. Dalmoro, P. Bertoncin, G. Lamberti,\nR. I. Moustafine, A. A. Barba, RSC Adv. 2018, 8, 34614. [146] D. Liu, F. Yang, F. Xiong, N. Gu, Theranostics 2016, 6, 1306. [147] C. Sahlgren, A. Meinander, H. Zhang, F. Cheng, M. Preis,\nC. Xu, T. A. Salminen, D. Toivola, D. Abankwa, A. Rosling, D. Ş. Karaman, O. M. H. Salo-Ahen, R. Österbacka, J. E. Eriksson, S. Willför, I. Petre, J. Peltonen, R. Leino, M. Johnson, J. Rosenholm, N. Sandler, Adv. Healthcare Mater. 2017, 6, 1700258. [148] P. Yingchoncharoen, D. S. Kalinowski, D. R. Richardson, Pharmacol. Rev. 2016, 68, 701. [149] R. A. Meyer, J. J. Green, Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol. 2016, 8, 191. [150] R. Chen, J. E. Wulff, M. G. Moffitt, Mol. Pharmaceutics 2018, 15, 4517. [151] C. Martins, F. Araújo, M. J. Gomes, C. Fernandes, R. Nunes, W. Li, H. A. Santos, F. Borges, B. Sarmento, Eur. J. Pharm. Biopharm. 2019, 138, 111. [152] D. Liu, H. Zhang, E. Mäkilä, J. Fan, B. Herranz-Blanco, C. F. Wang, R. Rosa, A. J. Ribeiro, J. Salonen, J. Hirvonen, H. A. Santos, Biomaterials 2015, 39, 249. [153] B. Herranz-Blanco, D. F. Liu, E. Makila, M. A. Shahbazi, E. Ginestar, H. B. Zhang, V. Aseyev, V. Balasubramanian, J. Salonen, J. Hirvonen, H. A. Santos, Adv. Funct. Mater. 2015, 25, 1488. [154] F. Fontana, M. A. Shahbazi, D. Liu, H. Zhang, E. Mäkilä, J. Salonen, J. T. Hirvonen, H. A. Santos, Adv. Mater. 2017, 29, 1603239. [155] S. W. Zeng, D. Baillargeat, H. P. Ho, K. T. Yong, Chem. Soc. Rev. 2014, 43, 3426. [156] J. Bai, B. X. Zhou, Chem. Rev. 2014, 114, 10131. [157] A. I. Lopez-Lorente, M. Valcarcel, B. Mizaikoff, Microchim. Acta 2014, 181, 1101. [158] L. L. Lazarus, A. S. J. Yang, S. Chu, R. L. Brutchey, N. Malmstadt, Lab Chip 2010, 10, 3377. [159] N. Visaveliya, J. M. Köhler, Small 2015, 11, 6435. [160] M. T. Rahman, P. G. Krishnamurthy, P. Parthiban, A. Jain, C. P. Park, D. P. Kim, S. A. Khan, RSC Adv. 2013, 3, 2897. [161] L. Zheng, G. Cai, S. Wang, M. Liao, Y. Li, J. A. Lin, Biosens. Bioelectron. 2019, 124, 143. [162] H. SadAbadi, S. Badilescu, M. Packirisamy, R. Wüthrich, Biosens. Bioelectron. 2013, 44, 77. [163] O. S. Wolfbeis, Chem. Soc. Rev. 2015, 44, 4743.\n1901943 (19 of 19)\nwww.advancedsciencenews.com\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim\nwww.small-journal.com\nSmall 2019, 1901943\n[164] S. Sreejith, R. Kishor, A. Abbas, R. Thomas, T. Yeo, V. D. Ranjan, R. Vaidyanathan, Y. P. Seah, B. G. Xing, Z. F. Wang, L. Zeng, Y. J. Zheng, C. T. Lim, ACS Appl. Mater. Interfaces 2019, 11, 4867. [165] B. R. Smith, S. S. Gambhir, Chem. Rev. 2017, 117, 901. [166] R. Kikkeri, P. Laurino, A. Odedra, P. H. Seeberger, Angew. Chem.,\nInt. Ed. Engl. 2010, 49, 2054. [167] B. H. Kwon, K. G. Lee, T. J. Park, H. Kim, T. J. Lee, S. J. Lee,\nD. Y. Jeon, Small 2012, 8, 3257. [168] K. Zhu, Y. M. Ju, J. J. Xu, Z. Y. Yang, S. Gao, Y. L. Hou, Acc. Chem.\nRes. 2018, 51, 404. [169] W. B. Lee, C. H. Weng, F. Y. Cheng, C. S. Yeh, H. Y. Lei, G. B. Lee,\nBiomed. Microdevices 2009, 11, 161. [170] S. J. Cho, S. M. Jung, M. Kang, H. S. Shin, J. H. Youk, Polymer\n2015, 69, 95. [171] A. Eatemadi, H. Daraee, N. Zarghami, H. Melat Yar, A. Akbarzadeh,\nBiotechnology 2016, 44, 111. [172] J. Cheng, Y. Jun, J. Qin, S. H. Lee, Biomaterials 2017, 114, 121. [173] Y. Cheng, Y. Yu, F. Fu, J. Wang, L. Shang, Z. Gu, Y. Zhao, ACS Appl.\nMater. Interfaces 2016, 8, 1080. [174] M. E. Kinahan, E. Filippidi, S. Köster, X. Hu, H. M. Evans,\nT. Pfohl, D. L. Kaplan, J. Wong, Biomacromolecules 2011, 12, 1504. [175] S. J. Shin, J. Y. Park, J. Y. Lee, H. Park, Y. D. Park, K. B. Lee, C. M. Whang, S. H. Lee, Langmuir 2007, 23, 9104. [176] S. K. Chae, E. Kang, A. Khademhosseini, S. H. Lee, Adv. Mater. 2013, 25, 3071. [177] M. A. Daniele, D. A. Boyd, A. A. Adams, F. S. Ligler, Adv. Healthcare Mater. 2015, 4, 11. [178] K. Takanari, R. Hashizume, Y. Hong, N. J. Amoroso, T. Yoshizumi, B. Gharaibeh, O. Yoshida, K. Nonaka, H. Sato, J. Huard, W. R. Wagner, Biomaterials 2017, 113, 31. [179] A. L. Thangawng, P. B. Howell Jr., J. J. Richards, J. S. Erickson, F. S. Ligler, Lab Chip 2009, 9, 3126. [180] J. Puigmartí-Luis, M. Rubio-Martínez, U. Hartfelder, I. Imaz, D. Maspoch, P. S. Dittrich, J. Am. Chem. Soc. 2011, 133, 4216. [181] X. Zhang, X. Gao, L. Jiang, J. Qin, Langmuir 2012, 28, 10026. [182] Y. Srivastava, M. Marquez, T. Thorsen, J. Appl. Polym. Sci. 2007, 106, 3171. [183] Y. Srivastava, I. Loscertales, M. Marquez, T. Thorsen, Microfluid.\nNanofluid. 2008, 4, 245.\n[184] N. Monteiro, M. Martins, A. Martins, N. A. Fonseca, J. N. Moreira, R. L. Reis, N. M. Neves, Acta Biomater. 2015, 18, 196. [185] M. Numata, Y. Takigami, M. Takayama, T. Kozawa, N. Hirose, Chem. - Eur. J. 2012, 18, 13008. [186] J. Jiang, Z. Li, H. Wang, Y. Wang, M. A. Carlson, M. J. Teusink, M. R. MacEwan, L. X. Gu, J. W. Xie, Adv. Healthcare Mater. 2016, 5, 2993. [187] S. Zhao, W. Su, V. Shah, D. Hobson, L. Yildirimer, K. W. K Yeung, J. Zhao, W. Cui, X. Zhao, Colloids Surf., B 2017, 157, 407. [188] D. Wei, J. Sun, J. Bolderson, M. L. Zhong, M. J. Dalby, M. Cusack, H. B. Yin, H. S. Fan, X. Zhang, ACS Appl. Mater. Interfaces 2017, 9, 14606. [189] B. R. Lee, K. H. Lee, E. Kang, D. S. Kim, S. H. Lee, Biomicrofluidics 2011, 5, 022208. [190] J. Cheng, D. Park, Y. Jun, J. Lee, J. Hyun, S. H. Lee, Lab Chip 2016, 16, 2654. [191] C. E. Cimenci, G. Uzunalli, O. Uysal, F. Yergoz, E. K. Umay, M. O. Guler, A. B. Tekinay, Acta Biomater. 2017, 60, 190. [192] S. B. Orr, A. Chainani, K. J. Hippensteel, A. Kishan, C. Gilchrist, N. W. Garrigues, D. S. Ruch, F. Guilak, D. Little, Acta Biomater. 2015, 24, 117. [193] C. Haynl, E. Hofmann, K. Pawar, S. Förster, T. Scheibel, Nano Lett. 2016, 16, 5917. [194] E. Kang, Y. Y. Choi, S. K. Chae, J. H. Moon, J. Y. Chang, S. H. Lee, Adv. Mater. 2012, 24, 4271. [195] N. Fereydouni, M. Darroudi, J. Movaffagh, A. Shahroodi, A. E. Butler, S. Ganjali, A. Sahebkar, J. Cell. Physiol. 2018, 234, 5537. [196] M. R. Safaee-Ardakani, A. Hatamian-Zarmi, S. M. Sadat, Z. B. Mokhtari-Hosseini, B. Ebrahimi-Hosseinzadeh, J. Rashidiani, H. Kooshki, Int. J. Biol. Macromol. 2018, 127, 27. [197] Y. Yu, G. Chen, J. Guo, Y. Liu, J. Ren, T. Kong, Y. Zhao, Mater. Horiz. 2018, 5, 1137. [198] N. J. Hao, Y. Nie, J. X. J. Zhang, ACS Sustainable Chem. Eng. 2018, 6, 1522. [199] D. Conchouso, D. Castro, S. A. Khan, I. G. Foulds, Lab Chip 2014, 14, 3011. [200] H. N. Chan, Y. F. Chen, Y. W. Shu, Y. Chen, Q. Wu, H. K. Tian, Microfluid. Nanofluid. 2015, 19, 9. [201] S. Waheed, J. M. Cabot, N. P. Macdonald, T. Lewis, R. M. Guijt, B. Paull, M. C. Breadmore, Lab Chip 2016, 16, 1993."
    } ],
    "references" : [ {
      "title" : "Adv",
      "author" : [ "G.T. Zan", "Q.S. Wu" ],
      "venue" : "Mater. 2016, 28",
      "citeRegEx" : "24",
      "shortCiteRegEx" : null,
      "year" : 2099
    }, {
      "title" : "ACS Nano 2010",
      "author" : [ "A. Jahn", "S.M. Stavis", "J.S. Hong", "W.N. Vreeland", "D.L. DeVoe", "M. Gaitan" ],
      "venue" : "4",
      "citeRegEx" : "134",
      "shortCiteRegEx" : null,
      "year" : 2077
    }, {
      "title" : "Angew",
      "author" : [ "R. Kikkeri", "P. Laurino", "A. Odedra", "P.H. Seeberger" ],
      "venue" : "Chem., Int. Ed. Engl. 2010, 49",
      "citeRegEx" : "166",
      "shortCiteRegEx" : null,
      "year" : 2054
    }, {
      "title" : "Lab Chip 2016",
      "author" : [ "S. Waheed", "J.M. Cabot", "N.P. Macdonald", "T. Lewis", "R.M. Guijt", "B. Paull", "M.C. Breadmore" ],
      "venue" : "16",
      "citeRegEx" : "201",
      "shortCiteRegEx" : null,
      "year" : 1993
    } ],
    "referenceMentions" : [ {
      "referenceID" : 1,
      "context" : "utilized HF microfluidics to fabricate LNPs with a desired relative standard deviation (Figure 3d).[134] The on-chip synthesis could also offer a platform to investigate the self-assembly process of lipid molecules under various reaction parameters.",
      "startOffset" : 99,
      "endOffset" : 104
    }, {
      "referenceID" : 1,
      "context" : "Reproduced with permission.[134] Copyright 2010, American Chemical Society.",
      "startOffset" : 27,
      "endOffset" : 32
    }, {
      "referenceID" : 1,
      "context" : "[134] Lipid Silicon wafer (HF) Continuous Vo/ Vi: 12 – 40 nm CV: 0.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 2,
      "context" : "proposed a single-phase microfluidic chip for the generation of carbohydrate-modified CdSe and CdTe NPs.[166] Owing to the high surface-to-volume ratio of the reaction flow in microchannels, the functionalized QDs could be generated under efficient mixing and low temperature.",
      "startOffset" : 104,
      "endOffset" : 109
    }, {
      "referenceID" : 3,
      "context" : "In addition, using this technology instead of traditional methods, the flexible design and preparation process of microfluidic chips is significantly simplified, which increases the accessibility to microfluidic technologies for much more research labs and accelerates the innovation in the field of microfluidic NMs.[200,201] In conclusion, the development of microfluidic technology in nanofabrication brings exciting opportunities to expand the biomedical application of NMs.",
      "startOffset" : 317,
      "endOffset" : 326
    } ],
    "year" : 2019,
    "abstractText" : "Dr. X. Zhao, Prof. L. Li, Prof. Y. J. Zhao Department of Endocrinology Zhongda Hospital School of Medicine Southeast University Nanjing 210009, P. R. China E-mail: li-ling76@hotmail.com; yjzhao@seu.edu.cn Dr. X. Zhao Research Institute of General Surgery Jinling Hospital Medical School of Nanjing University Nanjing 210002, P. R. China Dr. F. K. Bian, Dr. L. Y. Sun. Dr. L. J. Cai, Prof. Y. J. Zhao State Key Laboratory of Bioelectronics School of Biological Science and Medical Engineering Southeast University Nanjing 210096, P. R. China The ORCID identification number(s) for the author(s) of this article can be found under https://doi.org/10.1002/smll.201901943.",
    "creator" : "Adobe InDesign CS6 (Macintosh)"
  }
}